Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
769.33-
QQQ
716.250.03%
BTC/USD
78010.530.4151%
DIA
535.550.09%
GLD
409.230.08%
TLT
82.940.07%

CME Group Inc

CMENASDAQ
Trade with Public
Trade with Public
$285.80
4.861.73%
At close: Aug 28, 5:00 PM EST
$285.40
-0.40-0.14%
After Hours: Aug 28, 4:47 PM EST
Dividend: The dividend Ex-Date is in 9 days
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipDividendsCompareOptionsStock Report

CME Group Analyst Price Targets

Wall Street analyst price targets and consensus rating for CME Group (CME).

Price Target Range — 9 Quarters

Analyst Consensus — 17 Analysts

8Buy
6Hold
3Sell
Consensus RatingOutperform# Analysts17Avg. Consensus PT$278Upside to Avg. PT-2.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 19, 2026Deutsche BankBrian BedellDowngradeBuy→Hold$286→$270
Jul 23, 2026JP MorganKenneth WorthingtonPT RaiseUnderweight$249→$250
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Deutsche Bank Downgrades CME Group to Hold, Lowers Price Target to $270

Deutsche Bank analyst Brian Bedell downgrades CME Group (NASDAQ:CME) from Buy to Hold and lowers the price target from $286 to $270.
Benzinga Newsdesk

PRO
B of A Securities Maintains Underperform on CME Group, Raises Price Target to $230

B of A Securities analyst Craig Siegenthaler maintains CME Group (NASDAQ:CME) with a Underperform and raises the price target from $226 to $230.
Benzinga Newsdesk

PRO
Morgan Stanley Maintains Overweight on CME Group, Raises Price Target to $330

Morgan Stanley analyst Michael Cyprys maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $324 to $330.
Benzinga Newsdesk

PRO
Piper Sandler Maintains Overweight on CME Group, Lowers Price Target to $295

Piper Sandler analyst Patrick Moley maintains CME Group (NASDAQ:CME) with a Overweight and lowers the price target from $329 to $295.
Benzinga Newsdesk

PRO
Morgan Stanley Maintains Overweight on CME Group, Lowers Price Target to $324

Morgan Stanley analyst Michael Cyprys maintains CME Group (NASDAQ:CME) with a Overweight and lowers the price target from $353 to $324.
Benzinga Newsdesk

PRO
Barclays Maintains Equal-Weight on CME Group, Lowers Price Target to $270

Barclays analyst Benjamin Budish maintains CME Group (NASDAQ:CME) with a Equal-Weight and lowers the price target from $316 to $270.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved